Moderna, Inc.
NASDAQ:MRNA
34.62 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,236 | 6,848 | 19,263 | 17,736 | 274.49 | 48.036 | 122.512 | 176.974 | 101.536 |
| Cost of Revenue
| 1,464 | 4,693 | 5,416 | 2,617 | 7.933 | 31.021 | 454.082 | 20.537 | 15.114 |
| Gross Profit
| 1,772 | 2,155 | 13,847 | 15,119 | 266.557 | 17.015 | -331.57 | 156.437 | 86.422 |
| Gross Profit Ratio
| 0.548 | 0.315 | 0.719 | 0.852 | 0.971 | 0.354 | -2.706 | 0.884 | 0.851 |
| Reseach & Development Expenses
| 4,543 | 4,845 | 3,295 | 1,991 | 1,370.339 | 496.309 | 454.082 | 410.459 | 274.717 |
| General & Administrative Expenses
| 0 | 1,345 | 1,011 | 0 | 0 | 109.62 | 94.252 | 64.722 | 57.45 |
| Selling & Marketing Expenses
| 0 | 204 | 121 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,174 | 1,549 | 1,132 | 567 | 188.267 | 109.62 | 94.252 | 64.722 | 57.45 |
| Other Expenses
| 0 | -94 | -45 | -735 | -528.905 | 0 | -12.556 | -28.851 | -2.709 |
| Operating Expenses
| 5,717 | 6,300 | 4,427 | 1,823 | 1,029.701 | 593.756 | 535.778 | 446.33 | 325.307 |
| Operating Income
| -3,945 | -4,239 | 9,420 | 13,296 | -763.144 | -545.72 | -413.266 | -269.356 | -223.771 |
| Operating Income Ratio
| -1.219 | -0.619 | 0.489 | 0.75 | -2.78 | -11.361 | -3.373 | -1.522 | -2.204 |
| Total Other Income Expenses Net
| 338 | 297 | 155 | -11 | 18.631 | 31.004 | 28.858 | 13.36 | 8.603 |
| Income Before Tax
| -3,607 | -3,942 | 9,575 | 13,285 | -744.513 | -514.716 | -384.408 | -255.996 | -215.168 |
| Income Before Tax Ratio
| -1.115 | -0.576 | 0.497 | 0.749 | -2.712 | -10.715 | -3.138 | -1.447 | -2.119 |
| Income Tax Expense
| -46 | 772 | 1,213 | 1,083 | 2.551 | -0.695 | 0.326 | -0.08 | 1.043 |
| Net Income
| -3,561 | -4,714 | 8,362 | 12,202 | -747.064 | -514.021 | -384.734 | -255.916 | -216.211 |
| Net Income Ratio
| -1.1 | -0.688 | 0.434 | 0.688 | -2.722 | -10.701 | -3.14 | -1.446 | -2.129 |
| EPS
| -9.27 | -12.34 | 21.22 | 30.28 | -1.96 | -1.55 | -4.74 | -0.68 | -0.58 |
| EPS Diluted
| -9.27 | -12.34 | 20.1 | 28.31 | -1.96 | -1.55 | -4.74 | -0.68 | -0.58 |
| EBITDA
| -3,394 | -3,283 | 9,768 | 13,528 | -732 | -515 | -388.404 | -235.327 | -208.657 |
| EBITDA Ratio
| -1.049 | -0.479 | 0.507 | 0.75 | -2.78 | -11.361 | -3.373 | -1.406 | -2.055 |